Zenotech Laboratories Balance Sheet Annual

Trade

BSE: 532039 | NSE: - | ISIN: INE486F01012 | Sector: Biotechnology & Drugs

74.50 -2.06 (-2.69%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	1.82	11.14	0.00	0.00
Cashand Short Term Investments	1.82	11.14	2.41	2.46
Accounts Receivable- Trade Net	3.25	3.32	3.93	3.80
Total Receivables Net	4.85	4.00	4.43	4.70
Total Inventory	0.84	0.00	0.13	0.09
Other Current Assets Total	18.66	1.12	-	0.00
Total Current Assets	26.16	16.26	7.37	7.35
Property/ Plant/ Equipment Total- Net	67.54	70.36	71.19	76.41
Long Term Investments	1.38	1.25	0.68	0.68
Note Receivable- Long Term	4.46	3.49	2.42	1.23
Other Long Term Assets Total	6.66	9.50	12.42	0.18
Total Assets	106.21	100.87	94.08	85.84
Accounts Payable	2.81	3.48	2.07	1.92
Notes Payable/ Short Term Debt	0.00	0.00	0.00	0.00
Other Currentliabilities Total	10.72	10.01	10.60	10.20
Total Current Liabilities	13.52	16.61	15.58	14.95
Long Term Debt	0.00	0.00	6.00	20.66
Total Long Term Debt	0.00	0.00	6.00	20.66
Total Debt	0.00	0.00	6.00	20.66
Other Liabilities Total	2.14	2.00	1.87	1.83
Total Liabilities	15.66	18.60	23.44	37.44
Common Stock Total	61.03	61.03	61.03	61.03
Retained Earnings( Accumulated Deficit)	29.51	-188.30	-199.93	-222.17
Total Equity	90.54	82.27	70.64	48.41
Total Liabilities Shareholders' Equity	106.21	100.87	94.08	85.84
Total Common Shares Outstanding	6.10	6.10	6.10	6.10
Tangible Book Valueper Share Common Eq	14.84	13.48	11.57	7.93
Property/ Plant/ Equipment Total- Gross	-	106.78	105.13	101.48
Accumulated Depreciation Total	-	-41.39	-34.22	-27.25
Accrued Expenses	-	3.12	2.91	2.83
Additional Paid- In Capital	-	209.54	209.54	209.54
Cash	-	-	2.41	2.46
Short Term Investments	-	-	0.00	-
Prepaid Expenses	-	-	0.39	0.10